Effect of Subcutaneous Anti-CD20 Antibody-Mediated B Cell Depletion on Susceptibility to Pneumocystis Infection in Mice

Anti-CD20 antibody therapy is used for both cancer and autoimmune disease but has been shown to be associated with PneumocystisPneumocystis

Bibliographic Details
Main Authors: Guixiang Dai, Kristin Noell, Gisbert Weckbecker, Jay K. Kolls
Format: Article
Language:English
Published: American Society for Microbiology 2021-06-01
Series:mSphere
Online Access:https://journals.asm.org/doi/10.1128/mSphere.01144-20
id doaj-f0f0b4cd8cad40f0b7cab1d5bb3c5cd3
record_format Article
spelling doaj-f0f0b4cd8cad40f0b7cab1d5bb3c5cd32021-09-21T20:35:24ZengAmerican Society for MicrobiologymSphere2379-50422021-06-016310.1128/mSphere.01144-20Effect of Subcutaneous Anti-CD20 Antibody-Mediated B Cell Depletion on Susceptibility to Pneumocystis Infection in MiceGuixiang Dai0Kristin Noell1Gisbert Weckbecker2Jay K. Kolls3https://orcid.org/0000-0001-5151-6304Center for Translational Research in Infection and Inflammation, Tulane University School of Medicine, New Orleans, Louisiana, USACenter for Translational Research in Infection and Inflammation, Tulane University School of Medicine, New Orleans, Louisiana, USANovartis, Basel, SwitzerlandCenter for Translational Research in Infection and Inflammation, Tulane University School of Medicine, New Orleans, Louisiana, USA Anti-CD20 antibody therapy is used for both cancer and autoimmune disease but has been shown to be associated with PneumocystisPneumocystishttps://journals.asm.org/doi/10.1128/mSphere.01144-20
collection DOAJ
language English
format Article
sources DOAJ
author Guixiang Dai
Kristin Noell
Gisbert Weckbecker
Jay K. Kolls
spellingShingle Guixiang Dai
Kristin Noell
Gisbert Weckbecker
Jay K. Kolls
Effect of Subcutaneous Anti-CD20 Antibody-Mediated B Cell Depletion on Susceptibility to Pneumocystis Infection in Mice
mSphere
author_facet Guixiang Dai
Kristin Noell
Gisbert Weckbecker
Jay K. Kolls
author_sort Guixiang Dai
title Effect of Subcutaneous Anti-CD20 Antibody-Mediated B Cell Depletion on Susceptibility to Pneumocystis Infection in Mice
title_short Effect of Subcutaneous Anti-CD20 Antibody-Mediated B Cell Depletion on Susceptibility to Pneumocystis Infection in Mice
title_full Effect of Subcutaneous Anti-CD20 Antibody-Mediated B Cell Depletion on Susceptibility to Pneumocystis Infection in Mice
title_fullStr Effect of Subcutaneous Anti-CD20 Antibody-Mediated B Cell Depletion on Susceptibility to Pneumocystis Infection in Mice
title_full_unstemmed Effect of Subcutaneous Anti-CD20 Antibody-Mediated B Cell Depletion on Susceptibility to Pneumocystis Infection in Mice
title_sort effect of subcutaneous anti-cd20 antibody-mediated b cell depletion on susceptibility to pneumocystis infection in mice
publisher American Society for Microbiology
series mSphere
issn 2379-5042
publishDate 2021-06-01
description Anti-CD20 antibody therapy is used for both cancer and autoimmune disease but has been shown to be associated with PneumocystisPneumocystis
url https://journals.asm.org/doi/10.1128/mSphere.01144-20
work_keys_str_mv AT guixiangdai effectofsubcutaneousanticd20antibodymediatedbcelldepletiononsusceptibilitytopneumocystisinfectioninmice
AT kristinnoell effectofsubcutaneousanticd20antibodymediatedbcelldepletiononsusceptibilitytopneumocystisinfectioninmice
AT gisbertweckbecker effectofsubcutaneousanticd20antibodymediatedbcelldepletiononsusceptibilitytopneumocystisinfectioninmice
AT jaykkolls effectofsubcutaneousanticd20antibodymediatedbcelldepletiononsusceptibilitytopneumocystisinfectioninmice
_version_ 1717372142456143872